# EDGAR Filing Document

**Accession Number:** 0001838163
**File Stem:** 0001493152-26-023892
**Filing Date:** 2026-5
**Character Count:** 127493
**Document Hash:** 3229a777ee652ec71c703b663cf4be44
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-023892.hdr.sgml**: 20260515

**ACCESSION NUMBER**: 0001493152-26-023892

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 56

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260515

**DATE AS OF CHANGE**: 20260515

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Brand Engagement Network Inc.
- **CENTRAL INDEX KEY:** 0001838163
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40130
- **FILM NUMBER:** 26989198

**BUSINESS ADDRESS:**
- **STREET 1:** 300 DELAWARE AVE
- **STREET 2:** SUITE 210 #409
- **CITY:** WILMINGTON
- **STATE:** DE
- **ZIP:** 19801
- **BUSINESS PHONE:** 307-757-3650

**MAIL ADDRESS:**
- **STREET 1:** 300 DELAWARE AVE
- **STREET 2:** SUITE 210 #409
- **CITY:** WILMINGTON
- **STATE:** DE
- **ZIP:** 19801

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DHC Acquisition Corp.
- **DATE OF NAME CHANGE:** 20201229

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q**

(Mark One)

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the quarterly period ended March 31, 2026

**OR**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the transition period from ___________ to ___________

Commission file number **001-40130**

**Brand Engagement Network Inc.**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Delaware** | **98-1574798** |
| (State or other jurisdiction of | (I.R.S. Employer |
| incorporation or organization) | Identification No.) |
| **300 Delaware Ave** |  |
| **Suite 210** |  |
| **Wilmington, DE** | **19801** |
| (Address of Principal Executive Offices) | (Zip Code) |

---

**(307) 757-3650**

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, par value $0.0001 per share | BNAI | The Nasdaq Stock Market LLC |
| Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share | BNAIW | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| **Large accelerated filer** | ☐ | **Accelerated filer** | ☐ |
| Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
|  |  | Emerging growth company | ☒ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).

Yes ☐ No ☒

Indicate the number of shares outstanding of each of the registrant's classes of common stock, as of the latest practicable date.

As of May 15, 2026, 6,507,687 shares of the Issuer's common stock, $0.0001 par value per share, and 1,644,096 public warrants representing the right to acquire one share of the Issuer's common stock for $0.16, were outstanding.

**Table of Contents**

---

| | |
|:---|:---|
|  | **PAGE** |
| **[Part I. Financial Information](#HK_002)** | **4** |
| [Item 1. Financial Statements](#HK_003) | 4 |
| &nbsp;&nbsp;&nbsp;[Unaudited Condensed Consolidated Balance Sheets as of March 31, 2026 and December 31, 2025](#HK_004) | 4 |
| &nbsp;&nbsp;&nbsp;[Unaudited Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2026 and 2025](#HK_005) | 5 |
| &nbsp;&nbsp;&nbsp;[Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity for the Three Months Ended March 31, 2026 and 2025](#HK_006) | 6 |
| &nbsp;&nbsp;&nbsp;[Unaudited Condensed Consolidated Statement of Cash Flows For the Three Months Ended March 31, 2026 and 2025](#HK_007) | 7 |
| &nbsp;&nbsp;&nbsp;[Notes to Unaudited Condensed Consolidated Financial Statements](#HK_008) | 8 |
| [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](#sq_001) | 22 |
| [Item 3. Quantitative and Qualitative Disclosures About Market Risk](#sq_002) | 27 |
| [Item 4. Controls and Procedures](#sq_003) | 28 |
| **[Part II. Other Information](#sq_004)** | **29** |
| [Item 1. Legal Proceedings](#sq_005) | 29 |
| [Item 1A. Risk Factors](#sq_006) | 29 |
| [Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](#sq_007) | 29 |
| [Item 3. Defaults Upon Senior Securities](#sq_008) | 29 |
| [Item 4. Mine Safety Disclosures](#sq_009) | 29 |
| [Item 5. Other Information](#sq_010) | 29 |
| [Item 6. Exhibits](#sq_011) | 30 |
| **[Signatures](#sq_012)** | **32** |

---

Brand Engagement Network, BEN, our logo and our other trademarks or service marks appearing in this report are the property of Brand Engagement Network Inc. Trade names, trademarks and service marks of other companies appearing in this report are the property of their respective owners. Solely for convenience, the trademarks, service marks and trade names included in this report are without the®,™ or other applicable symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensors to these trademarks, service marks and trade names.

Unless otherwise indicated, "Brand Engagement Network," "BEN," "the Company," "our," "us," or "we," refer to Brand Engagement Network Inc. and its consolidated subsidiaries.

[**Table of Contents**](#HK_001)

**CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS**

This Quarterly Report on Form 10-Q (this "Report") contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Rule 175 promulgated thereunder, and Section 21E of the Securities Exchange Act of 1934, as amended, and Rule 3b-6 promulgated thereunder and are intended to be covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally relate to future events or our future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as "aims," "anticipates," "believes," "contemplates," "continue," "could," "estimates," "expects," "forecast," "guidance," "intends," "may," "plans," "possible," "potential," "predicts," "preliminary," "projects," "seeks," "should," "target," "will" or "would" or the negative of these words, variations of these words or other similar terms or expressions that concern our expectations, strategy, plans, or intentions.

Such forward-looking statements are subject to certain risks, uncertainties and assumptions relating to factors that may be outside of our control could cause actual results to differ materially from those anticipated in such statements, including those identified below, under "*Part II, Item 1A. Risk Factors*," and elsewhere herein:

● our ability to develop and attain market acceptance for our products and services;

● our ability to maintain the listing of our securities on the Nasdaq Stock Market ("Nasdaq");

● cybersecurity risks that may affect us directly or may impact us indirectly by virtue of their effects on our clients, markets or vendors, including our ability to identify and address cybersecurity risks, including those posed by the increasing use of artificial intelligence (such as, but not limited to, ransomware, data security breaches, "denial of service" attacks, "hacking" and identity theft) affecting us, our clients, and our third-party vendors and service providers;

● the attraction and retention of qualified directors, officers, employees and key personnel;

● our need for additional capital and whether additional financing will be available on favorable terms, or at all;

● the lack of a market for our Common Stock and Public Warrants and the volatility of the market price and trading price for our Common Stock and Public Warrants;

● our ability to meet the conditions to close, including the raising of sufficient financing to fund our pending acquisition (the "Cataneo Acquisition") of Cataneo Gmbh ("Cataneo"), our ability to pay down payments in accordance with the purchase agreement and our ability to integrate and realize the anticipated benefits of the Cataneo Acquisition;

● the impact of lawsuits and other litigation matters on our business;

● our limited operating history;

● the length of our sales cycle and the time and expense associated with it;

● our ability to grow our customer base;

● our dependence upon third-party service providers for certain technologies;

● competition from other companies offering artificial intelligence products that have greater resources, technology, relationships and/or expertise;

● our ability to compete effectively in a highly competitive market;

● our ability to protect and enhance our corporate reputation and brand;

● our ability to hire, retain, train and motivate qualified personnel and senior management and our ability to deploy our personnel and resources to meet customer demand;

● our ability to grow through acquisitions and successfully integrate any such acquisitions;

● the impact from future regulatory, judicial, and legislative changes in our industry;

● increases in costs, disruption of supply or shortage of materials, which could harm our business;

● our ability to successfully maintain, protect, enforce and grow our intellectual property rights;

● our future financial performance, including the ability of future revenues to meet projected annual bookings;

● our ability to forecast and maintain an adequate rate of revenue growth and appropriately plan our expenses;

● our ability to generate sufficient revenue from each of our revenue streams; and

● other risks, uncertainties and factors set forth in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the "2025 Annual Report").

The foregoing factors should not be construed as exhaustive and should be read together with the other cautionary statements included in this in this Report, which is incorporated by reference herein. If one or more events related to these or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, actual results may differ materially from what we anticipate. Many of the important factors that will determine these results are beyond our ability to control or predict. Accordingly, you should not place undue reliance on any such forward-looking statements. Any forward-looking statement speaks only as of the date on which it is made, and, except as otherwise required by law, we do not undertake any obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise. New factors emerge from time to time, and it is not possible for us to predict which will arise. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

[**Table of Contents**](#HK_001)

 ****

***Part I. Financial Information***

**Item 1. Financial Statements**

**BRAND ENGAGEMENT NETWORK INC.**

**UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS**

---

| | | |
|:---|:---|:---|
|  | **March 31, 2026** | **December 31, 2025\*\*** |
| ASSETS |  |  |
| Current assets |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $1801011 | $172124 |
| &nbsp;&nbsp;&nbsp;Accounts receivable, net of allowance | 130415 | 250120 |
| &nbsp;&nbsp;&nbsp;Prepaid and other current assets | 1665548 | 1213777 |
| Total current assets | 3596974 | 1636021 |
| Property and equipment, net | 278777 | 287073 |
| Intangible assets, net | 12151882 | 13050901 |
| Right of use asset | 282859 | 329505 |
| Total assets | $16310492 | $15303500 |
| LIABILITIES AND STOCKHOLDERS' EQUITY |  |  |
| Current liabilities |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | $3361217 | $5042010 |
| &nbsp;&nbsp;&nbsp;Accrued expenses | 3872270 | 3666784 |
| &nbsp;&nbsp;&nbsp;Short-term debt | 318521 | 1342352 |
| &nbsp;&nbsp;&nbsp;Convertible debt | 760000 | 760000 |
| Total current liabilities | 8312008 | 10811146 |
| Lease liability, non-current | 289136 | 309752 |
| Warrant liabilities | 427465 | 721758 |
| Total liabilities | 9028609 | 11842656 |
| Commitments and contingencies (Note I) |  |  |
| Stockholders' equity |  |  |
| &nbsp;&nbsp;&nbsp;Preferred stock par value $0.0001 per share, 1,000,000 shares authorized, none designated. No shares issued or outstanding as of March 31, 2026 and December 31, 2025 |  |  |
| &nbsp;&nbsp;&nbsp;Common stock par value of $0.0001 per share, 75,000,000 shares authorized; 6,491,925 shares issued and outstanding as of March 31, 2026, 5,783,524 shares issued and outstanding as of December 31, 2025 (\*) | 649 | 578 |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital | 65984795 | 59102850 |
| &nbsp;&nbsp;&nbsp;Accumulated deficit | (58703561) | (55642584) |
| Total stockholders' equity | 7281883 | 3460844 |
| Total liabilities and stockholders' equity | $16310492 | $15303500 |

---

(\*) Adjusted retroactively for reverse stock split, see Note G <br> (\*\*) Derived from the audited information

*The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.*

[**Table of Contents**](#HK_001)

**BRAND ENGAGEMENT NETWORK INC.**

**UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS**

---

| | | |
|:---|:---|:---|
|  | **For the three months ended<br>March 31,** | **For the three months ended<br>March 31,** |
|  | **2026** | **2025** |
| Revenue | $104311 | $10000 |
| Operating expenses |  |  |
| &nbsp;&nbsp;&nbsp;General and administrative expenses | 2363904 | 3214189 |
| &nbsp;&nbsp;&nbsp;Research and development | 26944 | 10697 |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 1047411 | 939206 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 3438259 | 4164092 |
| Loss from operations | (3333948) | (4154092) |
| Other income (expense) |  |  |
| &nbsp;&nbsp;&nbsp;Interest expense, net | (57607) | (125042) |
| &nbsp;&nbsp;&nbsp;Change in fair value of warrant liabilities | 294293 | 614892 |
| &nbsp;&nbsp;&nbsp;Gain on debt extinguishment | 89340 |  |
| &nbsp;&nbsp;&nbsp;Other income (expense), net | (6066) | 54012 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other income, net | 319960 | 543862 |
| Loss before income tax expense | (3013988) | (3610230) |
| Income tax expense | (46989) | - |
| Net loss | $(3060977) | $(3610230) |
| Net loss per common share, basic and diluted (\*) | $(0.51) | $(0.90) |
| Weighted average number of common shares outstanding, basic and diluted (\*) | 5967831 | 4014036 |

---

(\*) Adjusted retroactively for reverse stock split, see Note G

*The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.*

[**Table of Contents**](#HK_001)

**BRAND ENGAGEMENT NETWORK INC.**

**UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Preferred Stock** | **Preferred Stock** | **Common stock** | **Common stock** | | | |
|  | **Shares** | **Amount** | **Shares** | **Amount** | **Additional Paid-in**<br>**Capital** | **Accumulated**<br>**Deficit** |<br>**Total** |
| Balance, December 31, 2025 |  | $- | 5783524 | $578 | $59102850 | $(55642584) | $3460844 |
| Sale of common stock |  |  | 30752 | 3 | 1542979 |  | 1542982 |
| Stock issued in conversion of convertible notes |  |  | 28871 | 3 | 391032 |  | 391035 |
| Stock issued for Standby Equity Purchase Agreement liability |  |  |  |  | 183895 |  | 183895 |
| Warrant exercises |  |  | 646059 | 65 | 4447069 |  | 4447134 |
| Stock-based compensation |  |  |  |  | 112000 |  | 112000 |
| Stock issued in settlement of liabilities |  |  | 2719 |  | 204970 |  | 204970 |
| Net loss |  | - | - | - | - | (3060977) | (3060977) |
| Balance, March 31, 2026 |  | $- | 6491925 | $649 | $65984795 | $(58703561) | $7281883 |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Preferred Stock** | **Preferred Stock** | **Common stock (\*)** | **Common stock (\*)** | | | |
|  | **Shares** | **Amount** | **Shares** | **Amount** | **Additional Paid-in**<br>**Capital** | **Accumulated**<br>**Deficit** |<br>**Total** |
| Balance, December 31, 2024 |  | $- | 3816899 | $382 | $49661259 | $(47017149) | $2644492 |
| Sale of common stock |  |  | 118643 | 12 | 1325530 |  | 1325542 |
| Stock issued in conversion of convertible notes |  |  | 31667 | 3 | 379997 |  | 380000 |
| Stock issued for Standby Equity Purchase Agreement liability |  |  | 64357 | 6 | 432476 |  | 432482 |
| Warrant exercises |  |  | 78713 | 8 | 1499542 |  | 1499550 |
| Stock-based compensation, including vested restricted shares |  |  | 22359 | 2 | 374924 |  | 374926 |
| Stock issued in settlement of liabilities |  |  | 58803 | 6 | 265488 |  | 265494 |
| Net loss |  | - | - | - | - | (3610230) | (3610230) |
| Balance, March 31, 2025 |  | $- | 4191441 | $419 | $53939216 | $(50627379) | $3312256 |

---

(\*) Adjusted retroactively for reverse stock split, see Note G

*The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.*

[**Table of Contents**](#HK_001)

**BRAND ENGAGEMENT NETWORK INC.**

**UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS**

---

| | | |
|:---|:---|:---|
|  | **For the three months ended<br> March 31,** | **For the three months ended<br> March 31,** |
|  | **2026** | **2025** |
| CASH FLOWS FROM OPERATING ACTIVITIES |  |  |
| Net loss | $(3060977) | $(3610230) |
| Adjustments to reconcile net loss to net cash used for operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization expense | 1047411 | 939206 |
| &nbsp;&nbsp;&nbsp;Change in fair value of warrant liabilities | (294293) | (614892) |
| &nbsp;&nbsp;&nbsp;Equity based compensation | 112000 | 369601 |
| &nbsp;&nbsp;&nbsp;Non-cash interest expense | 57607 | 86042 |
| &nbsp;&nbsp;&nbsp;Reduction in the right of use asset | 46646 | 43141 |
| Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Accounts receivable | 119705 | (10000) |
| &nbsp;&nbsp;&nbsp;Prepaid and other current assets | (451771) | (558402) |
| &nbsp;&nbsp;&nbsp;Accounts payable | (1680793) | 903961 |
| &nbsp;&nbsp;&nbsp;Accrued expenses | 400384 | (88927) |
| &nbsp;&nbsp;&nbsp;Lease liability | (20616) | (87362) |
| NET CASH USED IN OPERATING ACTIVITIES | (3724697) | (2627862) |
| CASH FLOWS FROM INVESTING ACTIVITIES |  |  |
| Purchase of property and equipment | 8297 |  |
| Capitalized internal-use software costs | (148392) | (110274) |
| NET CASH USED IN INVESTING ACTIVITIES | (140095) | (110274) |
| CASH FLOWS FROM FINANCING ACTIVITIES |  |  |
| Proceeds received from option and warrant exercises | 4447134 | 1499550 |
| Repayments of short term debt | (50000) |  |
| Repayment of note payable | (630332) |  |
| Proceeds from the sale of common stock | 1542982 | 1325542 |
| Proceeds from Standby Equity Purchase Agreement liability | 183895 | - |
| NET CASH PROVIDED BY FINANCING ACTIVITIES | 5493679 | 2825092 |
| Net change in cash and cash equivalents | 1628887 | 86956 |
| Cash, beginning of period | 172124 | 149273 |
| Cash, end of period | $1801011 | $236229 |
| SUPPLEMENTAL NON-CASH DISCLOSURES |  |  |
| &nbsp;&nbsp;&nbsp;Issuance of common stock for Standby Equity Purchase Agreement liability | $- | $432482 |
| &nbsp;&nbsp;&nbsp;Stock-based compensation capitalized as part of capitalized software costs | $- | $5325 |
| &nbsp;&nbsp;&nbsp;Settlement of liabilities into common shares | $204970 | $265494 |
| &nbsp;&nbsp;&nbsp;Conversion of convertible notes into common shares | $391035 | $380000 |

---

*The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.*

[**Table of Contents**](#HK_001)

**BRAND ENGAGEMENT NETWORK INC.**

**NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**NOTE A - NATURE OF OPERATIONS AND GOING CONCERN**

*Nature of Operations*

Brand Engagement Network Inc. (formerly Blockchain Exchange Network Inc.) (together with its subsidiaries, "BEN" or "the Company") was formed in Jackson, Wyoming on April 17, 2018, and was named in honor of the renowned Founding Father and inventor, Benjamin Franklin. In 2019, the Company became a wholly-owned subsidiary of Datum Point Labs ("DPL"), and then was spun out of DPL in May 2021. BEN acquired DPL in December 2021.

The Company is an artificial intelligence ("AI") platform provider, designed to interface with emerging technologies, including blockchain, internet of things, and cloud computing, that drives digital transformation across various industries. BEN offers a suite of configured and customizable applications, including natural language processing, anomaly detection, encryption, recommendation engines, sentiment analysis, image recognition, personalization, and real-time decision-making. These applications help companies improve customer experiences, optimize cost drivers, mitigate risks, and enhance operational efficiency.

*Liquidity and Going Concern*

The accompanying unaudited condensed consolidated financial statements have been prepared as though the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. As of March 31, 2026, the Company had an accumulated deficit of $58,703,561, and during the three months ended March 31, 2026, a net loss of $3,060,977 and net cash used in operating activities of $3,724,697. Management expects to continue to incur operating losses and negative cash flows from operations for at least the next 12 months. The Company has financed its operations to date from proceeds from the sale of Common Stock, exercises of warrants, the issuance of promissory notes and convertible debt, and its transactions with AFG Companies Inc. ("AFG"). The Company's current liquidity position raises substantial doubt about the Company's ability to continue as a going concern.

The Company believes that its existing cash and cash equivalents and proceeds from the May SPA, August SPA, and Yorkville Promissory Note (Note G) will be insufficient to meet its anticipated cash requirements for at least the next 12 months from the date the unaudited, condensed consolidated financial statements are issued. The Company will need to raise additional capital to continue to fund operations and product research and development. The Company believes that it will be able to obtain additional working capital through equity financings, additional debt, or other arrangements to fund future operations, and it intends to raise capital through equity or debt investments in the Company by third parties. However, the Company cannot conclude these are probable of being implemented or, if probable of being implemented, being in sufficient enough amounts to satisfy the Company's contractual amounts as they presently exist that are coming due over the next 12 months as of the date of this filing.

The assumptions upon which the Company has based its estimates are routinely evaluated and may be subject to change. The actual amount of the Company's expenditures will vary depending upon several factors including but not limited to the design, timing, and the progress of the Company's research and development programs, and the level of financial resources available. The Company can adjust its operating plan spending based on available financial resources.

The unaudited, condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

[**Table of Contents**](#HK_001)

**NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

*Basis of Presentation and Consolidation*

The unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP"). The Company's unaudited condensed consolidated financial statements include the accounts of the Company and the accounts of the Company's wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.

The accompanying unaudited condensed consolidated financial statements and related notes have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission ("SEC") for unaudited condensed consolidated financial information. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete consolidated financial statements. Certain information and footnote disclosure normally included in financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to instructions, rules, and regulations prescribed by the SEC.

*Unaudited Interim Results*

These unaudited condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company's annual audited financial statements and the notes thereto as of and for the year ended December 31, 2025 found in the 2025 Annual Report. The accompanying unaudited condensed consolidated financial statements as of March 31, 2026 and for the three months ended March 31, 2026 and 2025 are unaudited but have been prepared on the same basis as the annual audited financial statements and include all normal, recurring adjustments that management believes to be necessary for a fair presentation of the periods presented. Interim results are not necessarily indicative of results for a full year. Balance sheet amounts as of December 31, 2025 are found in the 2025 Annual Report.

*Use of Estimates*

The preparation of the accompanying unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results and outcomes could differ significantly from the Company's estimates, judgments, and assumptions. Significant estimates in the Company's unaudited, condensed consolidated financial statements include, but are not limited to, assumptions used to measure stock-based compensation, useful lives and impairment of intangible assets, warrant liabilities, and derivative liabilities.

These estimates and assumptions are based on management's best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions.

*Segment and Geographic Information*

Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision maker, or decision-making group, in deciding how to allocate resources in assessing performance. The Company's chief operating decision maker ("CODM") is the Chief Executive Officer. The CODM manages the Company's operations on a consolidated basis for the purpose of allocating resources. The Company views its operations as, and manages its business in, one operating and reporting segment.

[**Table of Contents**](#HK_001)

The accounting policies of its segment are the same as those described in the summary of significant accounting policies. The CODM assesses performance for its segment based on net loss, which is reported on the consolidated statements of operations. The measure of segment assets is reported on the unaudited, condensed consolidated balance sheet as total assets. The CODM uses cash forecast models in deciding how to invest into the segment. The CODM analyzes the Company's net loss and monitors budget versus actual results to assess the performance of the Company.

The Company has an office in the Republic of Korea dedicated to research and development activities.

*Significant Risks and Uncertainties*

There can be no assurance that the Company's research and development will be successfully commercialized. Developing and commercializing goods and services require significant time and capital and is subject to regulatory review and approval as well as competition from other AI technology companies. The Company operates in an environment of rapid change and is dependent upon the continued services of its employees and consultants and obtaining and protecting intellectual property.

*Revenue Recognition and Accounts Receivable*

The Company accounts for revenue in accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 606, *Revenue from Contracts with Customers* ("ASC 606") for all periods presented. The core principle of ASC 606 is to recognize revenue for the transfer of promised goods or services to customers in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. This principle is achieved by applying the following five-step approach:

&nbsp;&nbsp;&nbsp;&nbsp;1. *Identification of the Contract, or Contracts, with a Customer.* 

&nbsp;&nbsp;&nbsp;&nbsp;2. *Identification of the Performance Obligations in the Contract.* 

&nbsp;&nbsp;&nbsp;&nbsp;3. *Determination of the Transaction Price.* 

&nbsp;&nbsp;&nbsp;&nbsp;4. *Allocation of the Transaction Price to the Performance Obligations in the Contract.* 

&nbsp;&nbsp;&nbsp;&nbsp;5. *Recognition of Revenue when, or as, Performance Obligations are Satisfied.* 

Trade receivables represent amounts due from customers and are stated net of the allowance for doubtful accounts. The allowance for doubtful accounts is based on management's assessment of the collectability of specific customer accounts, the aging of the accounts receivable, historical experience, and other currently available evidence. If there is a deterioration of a major customer's credit worthiness or actual defaults are higher than the historical experience, management's estimates of the recoverability of amounts due the Company could be adversely affected. Trade receivables of the Company as of March 31, 2026 and December 31, 2025 are $130,415 and $250,120, respectively, net of an allowance for expected credit losses amounting to zero, respectively.

*Impairment of Definite Lived Intangible Assets*

The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If the carrying amount of the asset exceeds its estimated undiscounted net cash flows, before interest, the Company will recognize an impairment loss equal to the difference between its carrying amount and its estimated fair value. If impairment is recognized, the reduced carrying amount of the asset will be accounted for as its new cost. Generally, fair values are estimated using discounted cash flow, replacement cost or market comparison analyses. The process of evaluating for impairment requires estimates as to future events and conditions, which are subject to varying market and economic factors. Therefore, it is reasonably possible that a change in an estimate resulting from judgments as to future events could occur which would affect the recorded amounts of the asset. No impairment losses were recorded for the three months ended March 31, 2026 or 2025.

[**Table of Contents**](#HK_001)

 

*In-Process Research and Development*

The fair value of in-process research and development ("IPR&D") acquired in an asset acquisition, that has been determined to have alternative future uses in accordance with ASC Topic 350, *Intangibles-Goodwill and Other* ("ASC 350"), is capitalized as an indefinite-lived intangible asset until the completion of the related research and development activities in accordance with ASC 350 or the determination that impairment is necessary. If the related research and development is completed, the asset is reclassified as a definite-lived asset at the time of completion and is amortized over its estimated useful life as research and development costs in accordance with ASC 730-10-25-2(c) and ASC 350. During the second quarter of 2024, the Company's IPR&D was completed and reclassified as a definite-lived asset and began amortizing over its estimated useful life of 5 years.

During the three months ended March 31, 2026 and 2025, the Company did not recognize an impairment charge related to its indefinite-lived IPR&D.

*Research and Development Costs*

Costs incurred in connection with research and development activities are expensed as incurred. These costs include rent for facilities, hardware and software equipment costs, employee related costs, consulting fees for technical expertise, prototyping, and testing.

*Stock-Based Compensation*

The Company recognizes stock-based compensation for stock-based awards (including stock options, restricted stock units, and restricted stock awards) in accordance with ASC Topic 718, *Compensation - Stock Compensation*. Determining the appropriate fair value of stock-based awards requires numerous assumptions, some of which are highly complex and subjective. The Company estimates the fair value of its stock option and warrant awards on the grant date using the Black-Scholes option-pricing model. The fair value of each restricted stock award is measured as the fair value per share of the Company's Common Stock at the date of grant.

Stock-based awards generally vest subject to the satisfaction of service requirements, or the satisfaction of both service requirements and achievement of certain performance conditions or market and service conditions. For stock-based awards that vest subject to the satisfaction of service requirements or market and service conditions, stock-based compensation is measured based on the fair value of the award on the date of grant and is recognized as stock-based compensation on a straight-line basis over the requisite service period. For stock-based awards that have a performance component, stock-based compensation is measured based on the fair value on the grant date and is recognized over the requisite service period as achievement of the performance objective becomes probable.

The Black-Scholes option-pricing model requires the use of judgments and assumptions, including fair value of its Common Stock, the option's expected term, the expected price volatility of the underlying stock, risk free interest rates and the expected dividend yield.

The Black-Scholes model assumptions are further described below:

● Common stock - the fair value of the Company's Common Stock.

● Expected Term - The expected term of employee options with service-based vesting is determined using the "simplified" method, as prescribed in the SEC's Staff Accounting Bulletin No. 107, whereby the expected life equals the arithmetic average of the vesting term and the original contractual term of the option due to the Company's lack of sufficient historical data. The expected term of nonemployee options is equal to the contractual term.

● Expected Volatility - The Company lacks its own historical stock data. Therefore, it estimates its expected stock volatility based primarily on the historical volatility of a publicly traded set of peer companies.

● Risk-Free Interest Rate - The Company bases the risk-free interest rate on the U.S. Treasury yield curve commensurate with the expected term of each option.

● Expected Dividend -The Company has never declared or paid any cash dividends on its Common Stock and does not plan to pay cash dividends in the foreseeable future, and, therefore, uses an expected dividend yield of zero in its valuation models.

*Cash and Cash Equivalents*

The Company considers all highly-liquid investments, readily convertible to cash, and which have a remaining maturity date of three months or less at the date of purchase, to be cash equivalents. Cash and cash equivalents are recorded at fair value and are held for the purpose of meeting short-term liquidity requirements, rather than for investment purposes. The Company maintains its cash and cash equivalent balances in the form of business checking accounts and money market accounts, the balances of which, at times, may exceed federally insured limits. As of March 31, 2026, cash and cash equivalents in excess of federally insured limits was $1,381,549.

[**Table of Contents**](#HK_001)

 

*Capitalized Internal-Use Software Costs*

Pursuant to ASC 350-40, *Internal-Use Software*, the Company capitalizes development costs for internal use software projects once the preliminary project stage is completed, management commits to funding the project, and it is probable that the project will be completed, and the software will be used to perform the function intended. The Company ceases capitalization at such time as the computer software project is substantially complete and ready for its intended use. The determination that a software project is eligible for capitalization and the ongoing assessment of recoverability of capitalized software development costs requires considerable judgment by management with respect to certain external factors, including, but not limited to, estimated economic life and changes in software and hardware technologies.

The Company capitalizes costs for internal-use software once project approval, funding, and feasibility are confirmed. These costs primarily consist of external consulting fees and direct labor costs. When the internal-use software is ready for its intended use, the Company reclassifies the internal-use software to developed software intangible assets and amortizes the asset over an estimated useful life ranging from 3 to 5 years. No impairment losses were recorded for the three months ended March 31, 2026 or 2025.

*Leases*

The Company determines whether an arrangement is or contains a lease, its classification, and its term at the lease commencement date. Leases with a term greater than one year will be recognized on the unaudited, condensed consolidated balance sheet as right-of-use ("ROU") assets, current lease liabilities, and if applicable, long-term lease liabilities. The Company includes renewal options to extend the lease term where it is reasonably certain that it will exercise these options. Lease liabilities and the corresponding ROU assets are recorded based on the present values of lease payments over the lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes the appropriate incremental borrowing rates, which are the rates that would be incurred to borrow on a collateralized basis, over similar terms, amounts equal to the lease payments in a similar economic environment. Payments for non-lease components or that are variable in nature that do not depend on a rate or index are not included in the lease liability and are typically expensed as incurred. If significant events, changes in circumstances, or other events indicate that the lease term or other inputs have changed, the Company would reassess lease classification, remeasure the lease liability using revised inputs as of the reassessment date, and adjust the ROU assets. Lease expense is recognized on a straight-line basis over the expected lease term for operating classified leases.

*Foreign Currency Transactions*

Foreign currency transaction gains and losses are a result of the effect of exchange rate changes on transactions denominated in currencies other than the functional currency. Gains and losses arising from foreign currency transactions and the effects of remeasurements are captured within the net loss within the unaudited, condensed consolidated statement of operations. Foreign currency transaction gains and losses were not material for the three months ended March 31, 2026 and 2025.

*Warrant Liabilities*

The Company evaluates all of its financial instruments, including issued share purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC Topic 480, Distinguishing Liabilities from Equity, ASC Topic 505, Equity, and ASC Topic 815, Derivatives and Hedging ("ASC 815"). The Company accounts for the public warrants, each representing the right to acquire one share of Common Stock for $11.50 (the "Public Warrants") and the private placement warrants, each representing the right to acquire one share of Common Stock for $11.50 (the "Private Placement Warrants"), in accordance with the guidance contained in ASC 815 under which the warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Public Warrants and Private Placement Warrants as liabilities at their fair value and adjust the Public Warrants and Private Placement Warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company's unaudited condensed consolidated statements of operations.

[**Table of Contents**](#HK_001)

 

*Fair Value of Financial Instruments*

The Company accounts for financial instruments under ASC 820, Fair Value Measurements ("ASC 820"). This statement defines fair value, establishes a framework for measuring fair value in U.S. GAAP, and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements, ASC 820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three levels as follows:

Level 1 - quoted prices (unadjusted) in active markets for identical assets or liabilities;

Level 2 - observable inputs other than Level 1, quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, and model-derived prices whose inputs are observable or whose significant value drivers are observable; and

Level 3 - assets and liabilities whose significant value drivers are unobservable.

The following fair value hierarchy table presents information about the Company's assets and liabilities measured at fair value on a recurring basis:

SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON RECURRING BASIS

---

| | | | |
|:---|:---|:---|:---|
| | **Fair value measurement at reporting date using** | **Fair value measurement at reporting date using** | **Fair value measurement at reporting date using** |
| <br>**March 31, 2026** | **(Level 1)** | **(Level 2)** | **(Level 3)** |
| Liabilities: |  |  |  |
| Warrant liabilities - Public Warrants | $- | $268189 | $- |
| Warrant liabilities - Private Placement Warrants | - | 159276 | - |
| **Total Warrant Liabilities** | $**&nbsp;&nbsp;&nbsp;&nbsp; -** | $**427465** | $**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-** |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Fair value measurement at reporting date using** | **Fair value measurement at reporting date using** | **Fair value measurement at reporting date using** |
| <br>**December 31, 2025** | **(Level 1)** | **(Level 2)** | **(Level 3)** |
| Liabilities: |  |  |  |
| Warrant liabilities - Public Warrants | $- | $452826 | $- |
| Warrant liabilities - Private Placement Warrants | - | 268932 | - |
| **Total Warrant Liabilities** | $**&nbsp;&nbsp;&nbsp;&nbsp; -** | $**721758** | $**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-** |

---

The fair value of the Public Warrants and Private Placement Warrants is estimated based on the closing price of the Public Warrants, an observable market quote but is classified as a Level 2 fair value measurement due to the lack of an active market.

[**Table of Contents**](#HK_001)

 

*Net Loss per Common Share*

Basic loss per common share is computed by dividing the net loss available to common stockholders by the weighted average number of shares of Common Stock outstanding during the periods. Diluted loss per common share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue Common Stock were exercised or converted into Common Stock or resulted in the issuance of Common Stock that then shared in the loss of the Company. In computing diluted loss per common share, the treasury stock method assumes that outstanding instruments are exercised/converted, and the proceeds are used to purchase Common Stock at the average market price during the periods. Instruments may have a dilutive effect under the treasury stock method only when the average market price of the Common Stock during the period exceeds the exercise price/conversion rate of the instruments. The Company accounts for stock issued in spin-out transactions and consummations of mergers of entities under common control retrospectively. For diluted net loss per common share, the weighted-average number of shares of Common Stock is the same for basic net loss per common share due to the fact that when a net loss exists, potentially dilutive securities are not included in the calculation when the impact is anti-dilutive.

The following potentially dilutive securities are excluded from the calculation of weighted average shares of Common Stock outstanding because their inclusion would have been anti-dilutive:

SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

---

| | | |
|:---|:---|:---|
|  | **March 31, 2026** | **December 31, 2025** |
| Unvested restricted shares |  |  |
| Options | 1386400 | 1386400 |
| Warrants | 15794903 | 16440962 |
| Convertible note (as converted) | 604463 | 633334 |
| Total | 17785766 | 18460696 |

---

*Recently Issued but Not Yet Adopted Accounting Standards*

In November 2024, the FASB issued ASU 2024-03, *Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses*, which requires additional disclosure of certain amounts included in the expense captions presented on the Statement of Operations as well as disclosures about selling expenses. This ASU is effective on a prospective basis, with the option for retrospective application, for annual periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027. Early adoption is permitted for annual financial statements that have not yet been issued. The Company is currently evaluating the effect of this pronouncement on its disclosures.

**NOTE C - PREPAID EXPENSES AND OTHER CURRENT ASSETS**

Prepaid expenses and other current assets consisted of the following:

SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS

---

| | | |
|:---|:---|:---|
|  | **March 31, 2026** | **December 31, 2025** |
| Security deposits | $107226 | $107226 |
| Cataneo GmbH deposit | 650000 | 550000 |
| Prepaid VAT | 1993 | 1993 |
| Prepaid professional fees | 483804 | 424835 |
| Prepaid insurance | 376262 | 99437 |
| Other | 46263 | 30286 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | $1665548 | $1213777 |

---

[**Table of Contents**](#HK_001)

**NOTE D - PROPERTY AND EQUIPMENT, NET**

Property and equipment include equipment, furniture, and capitalized software. Furniture and equipment are depreciated using the straight-line method over estimated useful lives of three years. Capitalized software costs are amortized straight-line over an estimated useful life ranging from 5 to 10 years.

Property and equipment consists of the following:

SCHEDULE OF PROPERTY AND EQUIPMENT

---

| | | |
|:---|:---|:---|
|  | **March 31, 2026** | **December 31, 2025** |
| Equipment | $676785 | $676785 |
| Furniture | 13591 | 13591 |
| Capitalized software | 240515 | 240515 |
| Total | 930891 | 930891 |
| Accumulated depreciation and amortization | (652114) | (643818) |
| Property and equipment, net of accumulated depreciation and amortization | $278777 | $287073 |

---

For the three months ended March 31, 2026 and 2025, depreciation and amortization of property and equipment totaled $8,296 and $8,295, respectively.

**NOTE E - INTANGIBLE ASSETS**

The following table summarizes intangible assets included on the unaudited, condensed consolidated balance sheets:

SCHEDULE OF INDEFINITE - LIVED INTANGIBLE ASSETS

---

| | | | |
|:---|:---|:---|:---|
|  | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** |
|  | **Gross** | **Accumulated Amortization** | **Net** |
| Amortizing intangible assets: |  |  |  |
| &nbsp;&nbsp;&nbsp;Patent portfolio | $1265268 | $(693790) | $571478 |
| &nbsp;&nbsp;&nbsp;In-process research and development | 18692109 | (7111705) | 11580404 |
| Total | $19957377 | $(7805495) | $12151882 |

---

---

| | | | |
|:---|:---|:---|:---|
|  | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
|  | **Gross** | **Accumulated Amortization** | **Net** |
| Amortizing intangible assets: |  |  |  |
| &nbsp;&nbsp;&nbsp;Patent portfolio | $1264752 | $(658522) | $606230 |
| &nbsp;&nbsp;&nbsp;Developed technology | 18552529 | (6107858) | 12444671 |
| Total | $19817281 | $(6766380) | $13050901 |

---

Total amortization expense including amortization related to developed technology was $1,039,115 and $93,911 for the three months ended March 31, 2026 and 2025, respectively.

[**Table of Contents**](#HK_001)

Future amortization of intangible assets are estimated to be as follows:

SCHEDULE OF FINITE-LIVED INTANGIBLE ASSETS, FUTURE AMORTIZATION EXPENSE

---

| | |
|:---|:---|
| Remainder of 2026 | $3227227 |
| 2027 | 3841103 |
| 2028 | 3698532 |
| 2029 | 1305649 |
| 2030 | 79371 |
|  | $12151882 |

---

**NOTE F - DEBT**

*Convertible Notes*

On April 12, 2024, the Company issued a convertible promissory note to J.V.B. Financial Group, LLC, acting through its Cohen & Company Capital Markets division ("CCM") in the principal amount of $1,900,000 (the "Cohen Convertible Note"), to settle outstanding invoices totaling $1,900,000 related to investment banking services rendered to the Company in connection with the Business Combination. Beginning on October 14, 2024, interest will accrue at the fixed rate of 8% per annum on the outstanding principal amount until the Cohen Convertible Note is paid in full. Interest is payable monthly in cash or in-kind at the election of the Company. The Company may prepay the Cohen Convertible Note in whole or in part at any time or from time to time without penalty or premium. The Company may be required to prepay all or a portion of the Cohen Convertible Note upon the consummation of certain capital raising activities as described therein. The maturity date of the Cohen Convertible Note was March 14, 2025. During the three months ended March 31, 2026, the Company recognized $46,480 in interest expense related to the Cohen Convertible Note. As of March 31, 2026, the Company was in default of the Cohen Convertible Note. As of the date of this filing, Company management is in the process of negotiating with Cohen and Cohen has not initiated any actions against the Company.

On December 14, 2024 (the "First Conversion Date"), $760,000 of the Cohen Convertible Note converted into 63,333 shares of Common Stock at $12.00 per share (the "Floor Price"). On the 14th day of each successive month commencing with January 14, 2025 (each such day, an "Additional Conversion Date" and together with the First Conversion Date, the "Conversion Dates"), CCM may convert a portion of Cohen Convertible Note to a number of shares equal to (i) up to 20% of the outstanding principal balance of the Cohen Convertible Note plus accrued interest due under the Cohen Convertible Note divided by (ii) a price per share (the "Conversion Purchase Price") equal to 92.75% of the arithmetic average of the Daily Volume-Weighted Average Price ("VWAP") for the five VWAP Trading Days (as defined therein) ending on the VWAP Trading Day immediately preceding the applicable Conversion Date (subject to the Floor Price).

*Short-Term Loans*

As of March 31, 2026, the Company had a short-term loans with an outstanding principal balance of $368,520. During the three months ended March 31, 2026, the Company repaid $50,000 in cash. The remaining unpaid balance, including interest, was $318,520 which remains outstanding as of March 31, 2026. The loan bears interest at a rate of 12% per annum and mature upon demand.

**NOTE G - STOCKHOLDERS' EQUITY**

In December 2025, the Company effected a 1-for-10 reverse stock split of its common stock. All share and per share amounts in these financial statements and notes thereto have been retroactively adjusted to reflect the reverse stock split.

[**Table of Contents**](#HK_001)

On May 28, 2024, the Company entered into a Securities Purchase Agreement (the "May SPA") with certain investors (the "May Purchasers"), pursuant to which the Company agreed to issue and sell to the May Purchasers an aggregate of 198,000 shares of Common Stock of the Company at a price per share of $25.00 and an aggregate of 396,000 warrants to purchase 396,000 shares of Common Stock, which was divided into two tranches consisting of (i) 198,000 warrants immediately exercisable for a term of one year from (the "May One-Year Warrants") and (ii) 198,000 warrants immediately exercisable for a term of five years (the "May Five-Year Warrants," together with the May One-Year Warrants, the "May Warrants"), each with an exercise price of $25.00 per share, subject to customary adjustments, for an aggregate purchase price of $4,950,000.

On May 30, 2024, the Company issued to the May Purchasers an aggregate of 20,000 Shares and 40,000 Warrants (consisting of 20,000 One-Year Warrants and 20,000 Five-Year Warrants) for an aggregate gross proceeds of $500,000. Upon the issuances of such shares of Common Stock, an aggregate of 126,000 May One-Year Warrants and 126,000 May Five-Year Warrants were issued to the May Purchasers and were immediately exercisable. The remaining shares were issued to an escrow account and such shares along with the May Warrants remain in escrow until the conditions in the May SPA are satisfied. The May Purchasers are required to pay to the Company monthly cash installments in the amounts and on the dates as determined in the May SPA ending on October 29, 2024. For every $25.00 paid to the Company, the Company will release one share of Common Stock and two May Warrants from escrow to the May Purchasers. If a May Purchaser fails to pay its required funding by the respective deadline, the May Purchaser's entire commitment under the May SPA will become immediately due and payable. During the three months ended March 31, 2026, the Company issued 33,000 shares of Common Stock to the May Purchasers for proceeds of approximately $750,000. As of December 31, 2025, 190,130 May One-Year Warrants and 125,160 May Five-Year Warrants are outstanding.

On July 1, 2024, the Company entered into a separate Securities Purchase Agreement (the "July SPA") with The Williams Family Trust for the issuance and sale of 12,000 shares of Common Stock at a price per share of $25.00 and an aggregate of 24,000 warrants, consisting of (i) 12,000 warrants with a term of one year and (ii) 12,000 warrants with a term of five years for an aggregate purchase price of $300,000. The warrants are immediately exercisable for Common Stock at a price of $25.00 per share. As of March 31, 2026, all 24,000 warrants remain outstanding.

On August 26, 2024, the Company entered into a Securities Purchase Agreement (the "August SPA") with certain investors (the "August Purchasers"), pursuant to which the Company will issue and sell an aggregate of 118,500 shares of the Company's Common Stock at a price per share of $50.00, for an aggregate purchase price of $5,925,000.

In connection with the August SPA, on August 26, 2024 (the "Assignment Effective Date"), the Company entered into that certain share assignment and lockup release agreement (the "Assignment Agreement") with certain members of Sponsor and certain other existing stockholders and affiliates of the Company (collectively, the "Sponsor Members" and each a "Sponsor Member") and the August Purchasers, pursuant to which, as an inducement to enter into the August SPA, the August Purchasers assumed, all of the Sponsor Members' rights, title and interest in an aggregate of 118,500 shares of Common Stock (the "Sponsor Securities") held by Sponsor on their behalf as of the Assignment Effective Date (the "Assignment"). In exchange for the Assignment by the Sponsor Members of the Sponsor Securities to the August Purchasers, the Company agreed to release 125,250 shares of Common Stock from certain restrictions on transfer contained in either a (i) prior letter agreement by and among the Company's predecessor, DHC, Sponsor and the other signatories thereto or (ii) in certain lockup agreements executed by certain of the Sponsor Members in connection with the consummation of the Company's prior business combination. The Sponsor Members transferred an aggregate of 118,500 Sponsor Securities into an escrow account. The Sponsor Securities are released from the escrow account on a pro rata basis upon the making of the required fundings on the terms and conditions described in the August SPA. In the event an August Purchaser fails to make required funding contemplated by the August SPA, a pro rata portion of the Sponsor Securities shall be released from the escrow account to the Company and the Company will cancel such Sponsor Securities.

On August 30, 2024, in connection with the August SPA and the Assignment Agreement, the Company issued to the August Purchasers an aggregate of 10,000 shares for an aggregate gross proceeds of $500,000. The remaining shares were issued to an escrow account and such shares remain in escrow until the conditions in the August SPA are satisfied. The August Purchasers are required to pay to the Company monthly cash installments in the amounts and on the dates as determined in the August SPA ending on April 5, 2025.

[**Table of Contents**](#HK_001)

For every $50.00 paid to the Company, the Company will release one share of Common Stock under the August SPA and one share of Common Stock under the Assignment Agreement to the August Purchasers. If an August Purchaser fails to pay its required funding by the respective deadline, the investor's entire commitment under the August SPA will become immediately due and payable. As of March 31, 2026, the Company has experienced delays in funding from one of the investors under the August SPA in the aggregate amount of $0.2 million. The Company is uncertain and cannot guarantee whether such amounts or any future required fundings by investors will be made.

On January 13, 2025, the Company entered into the January Warrant Exercise Agreement with certain Purchasers. Pursuant to the August SPA, the Purchasers previously purchased 11,000 shares of Common Stock, and the Company issued the Contribution Warrant to purchase up to 96,000 shares of Common Stock at an exercise price of $50.00 per share in exchange for certain holders of Common Stock contributing 118,500 shares of Common Stock into an escrow account maintained in connection with the August SPA, of which 107,500 shares of Common Stock remain in such escrow account as of March 31, 2026.

Under the January Warrant Exercise Agreement, the exercise price of the Committed Warrants was reduced to $19.60 per share, until May 30, 2025, after which point the exercise price for any unexercised Committed Warrants shall automatically revert back to $25.00 per share. Pursuant to the January Warrant Exercise Agreement, the Purchasers agreed to exercise the Committed Warrants for cash on the Exercise Schedule. Upon each Committed Warrant exercised in accordance with the Exercise Schedule, the Company shall issue the Reload Warrants. Upon a Purchaser's completion in full under the Warrant Exercise but no later than May 30, 2025, all remaining May Warrants issued under the May SPA held by such Purchaser shall immediately upon completion of such exercise automatically be amended to become exercisable for $19.60 per share for the remainder of their term. If a Purchaser exercises an Optional Warrant by June 30, 2025, the Company shall issue the Optional Reload Warrants. In addition, under the January Warrant Exercise Agreement, for each share of Common Stock for which a Purchaser exercises a Committed Warrant, one Escrow Share will be released from escrow and transferred to such Purchaser, for an aggregate of up to 107,499 Escrow Shares among all Purchasers, rounded down to the nearest whole share. Additionally, the exercise price of the Contribution Warrant was reduced to $17.10 per share.

On January 29, 2026, the Company satisfied its remaining obligations under the May 2023 Asset Purchase Agreement by completing a final payment of $0.6 million to Hana Bank (South Korea). Additionally, during the quarter ended March 31, 2026, the Company completed $0.8 million in debt-to-equity conversions, further reducing outstanding liabilities.

On March 25, 2026, the Company closed a $1.5 million private placement with Ben Capital Fund I, LLC at a price of $63.25 per share. During the quarter, the Company also received approximately $4.5 million in cash proceeds from the exercise of outstanding warrants.

*Common Stock Warrants*

 

In connection with the Business Combination, the Company assumed 1,031,495 Public Warrants and 612,601 Private Placement Warrants, which are all outstanding as of March 31, 2026 and December 31, 2025. Each whole Public Warrant and Private Placement Warrant entitles the holder to purchase one share of the Company's Common Stock at an exercise price of $115.00 per share. The Public Warrants and Private Placement Warrants were exercisable beginning on April 13, 2024 and expire on April 14, 2029.

The Private Placement Warrants are identical to the Public Warrants, except that (x) the Private Placement Warrants and the Common Stock issuable upon the exercise of the Private Placement Warrants were not transferable, assignable or saleable until 30 days after the completion of a business combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable as described above so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

In connection with the May SPA, the Company also entered into a Letter Agreement to Exercise Warrants ("May Warrant Exercise Agreement") with certain of the May Purchasers (the "Required Warrant Parties"). Under the May Warrant Exercise Agreement, if the Company uses commercially reasonable efforts to raise an additional $3,250,000 in capital (excluding amounts raised under the May SPA) but is unable to do so by October 31, 2024, the Required Warrant Parties will be required to exercise for cash certain of their May Warrants on a monthly basis in the amounts and on the dates as determined in the May Warrant Exercise Agreement. For each May Warrant so exercised, the Company will issue one new May one-Year Warrant and one new May five-Year Warrant (collectively, "May Reload Warrants") each with an exercise price of $25.00 to the Required Warrant Party. A maximum of 260,000 May Reload Warrants may be issued pursuant to the May Warrant Exercise Agreement. Upon receipt of an aggregate of $3,250,000 of actual cash proceeds from the August SPA, the May Warrant Exercise Agreement will terminate automatically.

[**Table of Contents**](#HK_001)

On August 26, 2024, in connection with the August SPA and the Assignment Agreement, the Company entered into a warrant purchase agreement (the "August Warrant Agreement") with each of the warrant holders signatory thereto (the "Warrant holders"), pursuant to which the Company issued to the Warrant holders an aggregate of 96,000 warrants to purchase Common Stock (the "August Warrants"), with an exercise price of $50.00 per share with an expiration period of five years from the date of issuance.

**NOTE H -EQUITY-BASED COMPENSATION**

**Equity Compensation Plans**

*2021 Incentive Stock Option Plan*

 

In May 2021, the Company adopted the 2021 Incentive Stock Option Plan ("2021 Option Plan") that provides for the grant of the following types of stock awards: (i) incentive stock Options, (ii) non-statutory stock options, (iii) stock appreciation rights, (iv) restricted stock awards, (v) restricted stock unit awards, and (vi) other stock awards. The 2021 Option Plan was administered by the Company's Board of Directors (the "Board of Directors"). In connection with the Closing, all outstanding awards were assumed by BEN pursuant to the terms of the Business Combination Agreement and the Board of Directors declared that there will be no further issuances under the 2021 Option Plan. Forfeitures under the 2021 Option Plan are automatically added to shares available for issuance under the 2024 Plan.

*2024 Long-Term Incentive Plan*

 

In connection with the Closing, the 2024 Long-Term Incentive Plan (the "2024 Plan") became effective. The 2024 Plan provides for the grant of the following types of stock awards: (i) incentive stock options, (ii) nonqualified stock options, (iii) stock appreciation rights, (iv) restricted stock, (v) restricted stock units, (vi) performance awards, (vii) dividend equivalent rights, (viii) performance awards, (ix) performance goals, (x) tandem awards, (xi) prior plan awards, and (xii) other awards. The 2024 Plan is administered by the Board of Directors. The 2024 Plan awards are available to employees, officers and contractors. The option grants authorized for issuance under the 2024 Plan may total up to 2,942,245 shares of Common Stock. As of March 31, 2026 and December 31, 2025, 26,616 shares remained available for grant under the 2024 Plan.

**NOTE I - RELATED PARTY TRANSACTIONS**

On August 19, 2023, the Company entered into the Reseller Agreement, providing for, among other things, AFG to act as the Company's exclusive reseller of certain products on terms and conditions set forth therein and, as partial consideration to AFG for such services, the Company issued 175,000 shares of Common Stock with an aggregate fair value of $13,475,000 based on the closing stock price on the date of the Merger. Additionally, the Company issued AFG a warrant to purchase up to 375,000 shares of Common Stock, with each warrant exercisable for one share of Common Stock at an exercise price of $100.00 and a fair value of $25.20 per warrant (Note G). The Company terminated the Reseller Agreement in January 2025, resulting in the forfeiture of the 375,000 warrants.

*Advances to Officers and Directors*

 

Certain officers and directors advanced funds to or were advanced from the Company on an undocumented, non-interested bearing, due on demand basis. As of March 31, 2026 and December 31, 2025, there were no amounts owed to related parties were included within accrued expenses and accounts payable, respectively, in the accompanying consolidated balance sheet.

[**Table of Contents**](#HK_001)

**NOTE J - COMMITMENTS AND CONTINGENCIES**

The Company is subject to various legal and regulatory proceedings, claims, and assessments, as well as other contingencies, that arise in the ordinary course of business. The Company accrues for these contingencies when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. The Company regularly reviews and updates its accruals for contingencies and makes adjustments as necessary based on changes in circumstances and the emergence of new information.

***Litigation***

*AFG Litigation*

 

On January 16, 2025, the Company filed a lawsuit against AFG and its Chief Executive Officer, Ralph Wright Brewer III, in the Northern District of Texas, Dallas Division alleging fraudulent misrepresentation, breach of contract, and the concealment of a ransomware attack on its own network shortly before the Reseller Agreement was executed. Given that the litigation is not yet at issue, the Company is currently unable to estimate the potential range of recoverable damages or the potential loss or range of loss, if any, resulting from a favorable or unfavorable outcome.

On March 26, 2025, the Company filed a First Amended Complaint against AFG in the Southern District of New York alleging breach of contract against AFG with respect to the AFG Subscription Agreement. Specifically, the Company alleges that AFG failed to fund its required March 13, 2025 payment in the amount of $6,500,000. In the lawsuit, the Company seeks actual damages in the amount of the missed payment, pre- and post-judgment of interest, consequential damages and attorneys' fees and costs. It also seeks a declaration from the court that AFG was and is obligated to purchase an aggregate of $6.5 million of additional shares of the Company's Common Stock on each of the first four anniversaries of the Initial Offering Closing Date and Business Combination Closing (as defined in the AFG Subscription Agreement) pursuant to the AFG Subscription Agreement. On May 12, 2025, AFG filed an Answer and Counterclaims in which it denies the allegations of the lawsuit and asserts counterclaims for an unspecified amount of damages against the Company. Given that the litigation is not yet at issue, the Company is currently unable to estimate the potential range of recoverable damages or the potential loss or range of loss, if any, resulting from a favorable or unfavorable outcome.

*Related Party Investigation*

 

The Company's management team assigned an advisor to the Board to conduct an internal investigation of potential related party transactions with certain members of DHC Sponsor, LLC, prior to the merger with Brand Engagement Network, Inc. These matters are still under investigation.

From time to time, we may become involved in legal proceedings or be subject to claims arising in the ordinary course of our business. Apart from the foregoing, we are not presently a party to any other legal proceedings that we believe, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, cash flows or financial condition. Defending such proceedings is costly and can impose a significant burden on management and employees. The results of any current or future litigation cannot be predicted with certainty, and regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.

*Employment contracts*

 

The Company has entered into employment contracts with its officers and certain employees that provide for severance and continuation benefits in the event of termination of employment either by the Company without cause or by the employee for good reason, both as defined in the agreements, along with any unpaid vested options, equity or earned bonuses. In addition, in the event of termination of employment following a change in control, as defined in each agreement the employee shall receive a prorated bonus payment and severance payments (as defined in each agreement).

The Company has satisfied all obligations pursuant to the employment agreement with Mr. Chang through the date of his termination as chief executive officer, but is still negotiating his release agreement.

[**Table of Contents**](#HK_001)

*Skye LATAM*

 

In October 2025, the Company entered into an exclusive reseller agreement (the "Agreement") with Skye Inteligencia LATAM ("Skye"), pursuant to which the Company granted Skye the exclusive right to market and resell certain of the Company's services. In connection with the Agreement, the Company received a contingent preferred equity interest in Skye and a 25% common stock interest in Skye, and is entitled to a 35% share of Skye's future net revenues derived from the resold services. As Skye was a newly formed entity with no operations or revenue history at the time the Agreement was executed, the Company determined that collectability of substantially all consideration was not probable at inception and, accordingly, the Agreement did not meet the criteria for recognition under ASC 606. The preferred equity interest has been recorded as an equity security under ASC 321 with nominal value, and the 25% common stock interest, which had nominal value at the date of the Agreement, is accounted for under the equity method in accordance with ASC 323. Revenue attributable to the 35% revenue share will be recognized as the related sales occur in accordance with ASC 606.

*Africa Licensing Agreement*

On January 20, 2026, the Company executed a licensing partnership with Valio Technologies (Pty) Ltd. This agreement facilitates the Company's entry into the African market and includes a clinical AI pilot at Nelson Mandela University to evaluate the ELM™ technology in regulated healthcare and academic environments. Under the terms of the agreement, the Company maintains a 25% equity interest in the regional venture and a 35% recurring revenue share.

**NOTE K - SUBSEQUENT EVENTS**

Subsequent events have been evaluated through May 15, 2026, which represents the date the financial statements were available to be issued, and no events, other than those discussed below, have occurred through that date that would impact the unaudited, condensed consolidated financial statements.

On April 21, 2026, the Company was granted U.S. Patent No. 12,581,163, titled "Systems and Methods for Delivering User-Specific Messages." The patent encompasses systems designed to interpret user intent and execute automated actions across integrated data systems in real-time environments.

On April 21, 2026, the Company entered into a letter agreement with HighTide Energy, Inc. d/b/a Accelevate Solutions ("Accelevate"), a provider of AI-driven fleet management and infrastructure solutions, regarding a strategic investment and commercial collaboration. Subsequently, on May 7, 2026, following the completion of due diligence, the Company executed two definitive Reseller Agreements with Accelevate. These agreements provide the Company with exclusive reseller rights in Mexico for a five-year term and global reseller rights (excluding Mexico and Latin America) for its AI technology, with the Company entitled to 35% of gross revenue from sales. Additionally, the Company completed a $1,000,000 strategic minority investment in Accelevate's common stock, securing 100% warrant coverage, a board seat, and a right of first refusal for future acquisition.

On April 30, 2026, the Company entered into a definitive agreement to acquire Munich-based Cataneo GmbH ("Cataneo"), a provider of advertising management software and media broadcast solutions. The transaction allows the Company to apply its AI technology to live media systems, enhancing how advertisers and media companies handle monetization and engagement. The transaction is expected to close on or about June 30, 2026, subject to customary closing conditions. The transaction is valued at approximately $19.5 million, with payment in a combination of cash and equity. BEN has already advanced $1.0 million, and the Company has secured capital commitments of $8 million to fund the remaining cash consideration, $500,000 of which has funded via the sale of common stock at a price of $39.59 per share and warrants exercisable in one year for $39.59 per share of common stock and the remainder of which will fund prior to closing. Approximately $10.5 million of the consideration will be delivered in BEN common stock, priced at the 20-day volume-weighted average price of $39.59 per share - which represents a premium to BEN's recent trading levels. This structure eliminates reliance on discounted or dilutive capital and underscores BEN's disciplined execution and strong balance-sheet focus.

[**Table of Contents**](#HK_001)

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations**

*The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and the notes related thereto which are included elsewhere in this Quarterly Report on Form 10-Q (this "Report"). Unless the context otherwise requires, all references in this section to "we," "us," "our," the "Company" or "BEN" refer to Brand Engagement Network Inc., a Delaware corporation. The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our audited consolidated financial statements and related notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2025 ("2025 Annual Report") and with the unaudited condensed consolidated financial statements and related notes thereto presented in this Report.*

**Overview**

We are an emerging provider of conversational artificial intelligence ("AI") assistants, with the purpose of transforming engagement and analytics for businesses through our security-focused, multimodal communication and human-like AI assistants. Our AI assistants are built on proprietary natural language processing, anomaly detection, multisensory awareness, sentiment and environmental analysis, as well as real-time individuation and personalization capabilities. We believe these powerful tools will empower businesses to elevate customer experiences, optimize cost management and supercharge operational efficiency. Our platform is designed to configure, train and operate AI assistants that engage with professionals and consumers through multiple channels, boosting customer experience and providing instant personalized assistance for consumers in the automotive and healthcare markets.

We still hold significant intellectual property in the form of a patent portfolio that we believe will be a cornerstone of our artificial intelligence solutions for certain industries that we expect to target, including the automotive, healthcare, and financial services industries.

***Recent Events***

During the quarter ended March 31, 2026, Brand Engagement Network Inc. (the "Company") implemented a comprehensive realignment of its financial and operational framework. Management initiated a strategic program directed at the systematic retirement of legacy reorganization liabilities. These strategic actions, combined with debt conversions, resulted in a $2,814,047 reduction of the Company's total liabilities compared to the quarter ended March 21, 2025.

*Operational Results and Strategic Milestones:*

*Africa Licensing Agreement:* On January 20, 2026, the Company executed a licensing partnership with Valio Technologies (Pty) Ltd. This agreement facilitates the Company's entry into the African market and includes a clinical AI pilot at Nelson Mandela University to evaluate the ELM™ technology in regulated healthcare and academic environments. Under the terms of the agreement, the Company maintains a 25% equity interest in the regional venture and a 35% recurring revenue share.

*Settlement of Legacy Debt and Conversions:* On January 29, 2026, the Company satisfied its remaining obligations under the May 2023 Asset Purchase Agreement by completing a final payment of $630,332.46 to Hana Bank (South Korea). Additionally, during the quarter ended March 31, 2026, the Company completed $596,005 in debt-to-equity conversions, further reducing outstanding liabilities.

*Termination of Financing Facility:* On February 4, 2026, the Company formally terminated its $50 million Standby Equity Purchase Agreement (SEPA) facility to further streamline its capital structure.

*Commercial Deployment:* On March 2, 2026, the Company's AI Concierge transitioned from pilot phase to active guest-facing deployment at the Seven Visions Resort & Places, The Dvin. This deployment serves as a commercial validation of the Engagement Language Model (ELM™) within the hospitality sector.

*Private Placement and Warrant Activity:* On March 25, 2026, the Company closed a $1.518 million private placement with Ben Capital Fund I, LLC at a price of $63.25 per share. During the quarter, the Company also received approximately $4.47 million in cash proceeds from the exercise of outstanding warrants.

*Leadership Transition:* Effective March 31, 2026, Jon Leibowitz was appointed as Chairman of the Board of Directors, succeeding Bernard Puckett. Mr. Leibowitz previously served as the Chairman of the Federal Trade Commission (FTC) and as a senior partner at Davis Polk & Wardwell LLP. The Board believes his extensive experience in regulatory policy, consumer protection, and corporate governance supports the Company's strategic focus on privacy and enterprise-grade AI security. This transition was part of a planned governance update and did not result from any disagreement regarding the Company's operations or policies.

***Financing Registration Statements***

 ****

We currently do not have an effective registration statement on file with the Securities and Exchange Commission other than our Registration Statement on Form S-8 (File No. 333-292748) and our Registration Statement on Form S-4 (file No. 333-275058) filed with the SEC on January 15, 2026.

***Key Factors and Trends Affecting our Business***

***Productions and Operations***

 ****

We expect to continue to incur significant operating costs that will impact our future profitability, including research and development expenses as we introduce new products and improves existing offerings; capital expenditures for the expansion of our development and sales capacities and driving brand awareness; additional operating costs and expenses for production ramp-up; general and administrative expenses as we scale our operations; interest expense from debt financing activities; and selling and distribution expenses as we build our brand and market our products. To date, we have not yet sold any of our products beyond their pilot stage. As a result, we will require substantial additional capital to develop products and fund operations for the foreseeable future.

[**Table of Contents**](#HK_001)

***Revenues***

 ****

We are a development stage company and have not generated any significant revenue to date.

***Public Company Costs***

 ****

If we cease to become an emerging growth company, we will become subject to the provisions and requirements under Section 404(b) of the Sarbanes-Oxley Act of 2002, which will require us to undergo audits of our internal controls over financial reporting as part of our yearly financial statement audits, resulting in a significant increase in consultant and audit costs over previous levels going forward.

**Components of Results of Operations**

***Operating expenses***

***General and administrative expenses***

 **

General and administrative expenses consist of employee-related expenses including salaries, benefits, and stock-based compensation as well as fees paid for legal, accounting and tax services, consulting fees and facilities costs not otherwise included in research and development expense. We have and expect to further incur significant expenses as a result of being a public company, including expenses related to compliance with the rules and regulations of the SEC and Nasdaq, additional insurance, investor relations and other administrative expenses and professional services.

***Depreciation and amortization***

 ****

Depreciation expense relates to property and equipment which consists of equipment, furniture and capitalized software. Amortization expense relates to intangible assets.

***Research and development cost***

 ****

Costs incurred in connection with research and development activities are expensed as incurred. These costs include rent for facilities, hardware and software equipment costs, consulting fees for technical expertise, prototyping, and testing.

***Interest expense***

 ****

Interest expense consists of interest on our related party note payable and short-term debt.

***Interest income***

 ****

Interest income consists of interest earned on our excess cash.

***Change in fair value of warrant liabilities***

 ****

Change in fair value of warrant liabilities reflected the non-cash charge for changes in the fair value of the warrant liability that is subject to re-measurement at each balance sheet date.

***Other expenses***

 ****

Other expenses primarily consists of foreign currency gains or losses as a result of exchange rate fluctuations on transactions denominated in Korean won.

[**Table of Contents**](#HK_001)

**Results of Operations**

*Comparison of the Three Months Ended March 31, 2026 and 2025*

---

| | | | |
|:---|:---|:---|:---|
|  | **For the three months ended March 31,** | **For the three months ended March 31,** | |
|  | **2026** | **2025** |<br>**Increase (Decrease) $** |
| Revenue | $104311 | $10000 | $94311 |
| Operating expenses |  |  |  |
| &nbsp;&nbsp;&nbsp;General and administrative expenses | 2363904 | 3214189 | (850285) |
| &nbsp;&nbsp;&nbsp;Research and development | 26944 | 10697 | 16247 |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 1047411 | 939206 | 108205 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 3438259 | 4164092 | (725833) |
| Loss from operations | (3333948) | (4154092) | 820144 |
| Other income (expense) |  |  |  |
| Interest expense, net | (57067) | (125042) | 67435 |
| Change in fair value of warrant liabilities | 294293 | 614892 | (320599) |
| Gain (loss) on debt extinguishment | 89340 |  | 89340 |
| Other income (expense), net | (6066) | 54012 | (60078) |
| Total other income, net | 319960 | 543862 | (223902) |
| Loss before income tax benefit | (3013988) | (3610230) | 596242 |
| Income tax benefit (expense) | (46989) | - | (46989) |
| Net loss | $(3060977) | $(3610230) | $549253 |

---

*Revenues*

During the three months ended March 31, 2026 and 2025, revenue was immaterial.

*General and administrative expenses*

General and administrative expenses for the three months ended March 31, 2026 were approximately $2.4 million, decrease of approximately $0.8 million, compared to the three months ended March 31, 2025. The decrease was primarily due to a decrease of $0.2 million in professional fees, a decrease of in employee related costs of $0.5 million, and by a decrease in insurance of $0.1 million. We have only recently begun to raise proceeds through the offering of our Common Stock and convertible notes to investors and therefore expect, in the near term at a minimum, to continue to utilize the issuance of equity based instruments as compensation to reduce our cash outlays.

[**Table of Contents**](#HK_001)

*Depreciation and amortization expenses*

Depreciation and amortization expenses for the three months ended March 31, 2026 were approximately $1.0 million, an increase of approximately $0.1 million, compared to the three months ended March 31, 2025. The increase was primarily due to dates assets placed in service.

*Research and development expenses*

Research and development expenses for the three months ended March 31, 2026 were approximately $0.02, an increase of approximately $0.01 million, compared to the three months ended March 31, 2025. The increase in research and development expenses were primarily due to consulting related expenses.

*Change in fair value of warrant liabilities*

Change in fair value of the warrant liabilities for the three months ended March 31, 2026 was approximately $0.3 million associated with the non-cash charge for changes in the fair value of the warrant liabilities that is subject to re-measurement at each balance sheet date. The change in the fair value of the warrant liabilities was minimal during the three months ended March 31, 2025.

**Liquidity and Capital Resources**

***Capital Resources and Available Liquidity***

 ****

The accompanying unaudited condensed consolidated financial statements have been prepared as though the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. As of March 31, 2026, the Company had an accumulated deficit of $58,703,561, a net loss of $3,060,977 and net cash used in operating activities of $4,467,029 during the three months ended March 31, 2026. Management expects to continue to incur operating losses and negative cash flows from operations for at least the next 12 months. The Company has financed its operations to date from proceeds from the sale of Common Stock, exercises of warrants, the issuance of promissory notes and convertible debt, and its transactions with AFG Companies Inc. ("AFG"). The Company's current liquidity position raises substantial doubt about the Company's ability to continue as a going concern.

The Company believes that its existing cash and cash equivalents and proceeds from the May SPA, August SPA, and Yorkville Promissory Note (Note G) will be insufficient to meet its anticipated cash requirements for at least the next 12 months from the date the consolidated financial statements are issued. The Company will need to raise additional capital to continue to fund operations and product research and development. The Company believes that it will be able to obtain additional working capital through equity financings, additional debt, or other arrangements to fund future operations, and it intends to raise capital through equity or debt investments in the Company by third parties. However, the Company cannot conclude these are probable of being implemented or, if probable of being implemented, being in sufficient enough amounts to satisfy the Company's contractual amounts as they presently exist that are coming due over the next 12 months as of the date of such filing.

The assumptions upon which the Company has based its estimates are routinely evaluated and may be subject to change. The actual amount of the Company's expenditures will vary depending upon several factors including but not limited to the design, timing, and the progress of the Company's research and development programs, and the level of financial resources available. The Company can adjust its operating plan spending based on available financial resources.

***Cash Exercise of Warrants***

 ****

There is no assurance that the holders of our warrants described under this section will elect to exercise for cash any or all of such warrants, especially when the trading price of our Common Stock is less than the exercise price per share of such warrants. We believe the likelihood that warrantholders will exercise their respective warrants, and therefore the amount of cash proceeds that we would receive, is dependent upon the trading price of our Common Stock. If the trading price for our Common Stock is less than the exercise price per share of a warrant, we expect that a warrantholder would not exercise their warrants. To the extent that any warrants are exercised on a "cashless basis" under certain conditions, we would not receive any proceeds from the exercise of such warrants.

[**Table of Contents**](#HK_001)

We intend to seek additional funds, primarily through the issuance of debt or equity securities for cash to operate our business, including through the business development activities discussed above to continue to support our operations. Therefore, the availability or unavailability of any proceeds from the exercise of our warrants is not expected to affect our ability to fund our operations. We will continue to evaluate the probability of warrant exercise over the life of our warrants and the merit of including potential cash proceeds from the exercise thereof in our liquidity sources and capital resources planning.

To the extent such warrants are exercised, additional Common Stock will be issued, which will result in dilution to the holders of our Common Stock and increase the number of shares of Common Stock eligible for resale in the public market. Sales of substantial numbers of such shares in the public market could adversely affect the market price of our Common Stock, which increases the likelihood of periods when our Warrants will not be in the money prior to their expiration.

**Cash Flows**

The following table summarizes our cash flows for the periods presented:

---

| | | |
|:---|:---|:---|
|  | **For the three months ended March 31,** | **For the three months ended March 31,** |
|  | **2026** | **2025** |
| Cash used in operating activities | $(3724697) | $(2627862) |
| Cash used in investing activities | (140095) | (110274) |
| Cash provided by financing activities | 5493679 | 2825092 |
| Net decrease in cash and cash equivalents | $1628887 | $86956 |

---

*Operating activities*

Cash used in operating activities was approximately $3.7 million during the three months ended March 31, 2026 primarily due to our net loss of approximately $3.1 million. The net loss included non-cash charges of approximately $0.9 million, which consisted of approximately $1.0 million of depreciation and amortization expense, and noncash interest expense, partially offset by $0.3 million gain due to the change in fair value of warrant liabilities. The net cash outflow of approximately $2.2 million from changes in our operating assets and liabilities was primarily due to a decrease in accounts payable of $1.6 million, offset by an increase in prepaid expense and other current assets of $0.5 million and a decrease in operating lease liability of $0.0 million.

Cash used in operating activities was approximately $2.6 million during the three months ended March 31, 2025 primarily due to our net loss of approximately $3.6 million. The net loss included non-cash charges of approximately $0.8 million, which consisted of approximately $0.9 million of depreciation and amortization expense, $0.4 million in equity-based compensation expense, including the issuance of restricted shares, and noncash interest expense, partially offset by $0.6 million gain due to the change in fair value of warrant liabilities. The net cash inflow of approximately $0.2 million from changes in our operating assets and liabilities was primarily due to an increase in accounts payable of $0.9 million, offset by an increase in prepaid expense and other current assets of $0.6 million and a decrease in operating lease liability of $0.1 million.

*Investing activities*

Cash used in investing activities during the three months ended March 31, 2026 was approximately $0.1 million, which consisted primarily of capitalized internal-use software costs.

Cash used in investing activities during the three months ended March 31, 2025 was approximately $0.2 million, which consisted primarily of capitalized internal-use software costs.

*Financing activities*

 

Cash provided financing activities during the three months ended March 31, 2026 was approximately $5.5 million, which consisted of proceeds received from the proceeds from warrant exercises

Cash provided financing activities during the three months ended March 31, 2025 was approximately $2.8 million, which consisted of proceeds received from the sale of Common Stock and proceeds from warrant exercises.

[**Table of Contents**](#HK_001)

**Critical Accounting Policies**

Our consolidated financial statements are prepared in accordance with U.S. GAAP. The preparation of our consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reported period. We base our estimates on historical experience, known trends and events and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions and conditions.

During the three months ended March 31, 2026, there were no material changes to our critical accounting policies and estimates from those described under the heading "Management's Discussion and Analysis of Financial Condition and Results of Operations of BEN", found in our 2025 Annual Report.

**Recent Accounting Pronouncements**

See Note B to our consolidated financial statements, found in our 2025 Annual Report for a description of recent accounting pronouncements applicable to our unaudited condensed consolidated financial statements.

**Off-Balance Sheet Financing Arrangements**

We have no obligations, assets or liabilities that would be considered off-balance sheet arrangements as of March 31, 2026. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

**Emerging Growth Company Status**

We are an "emerging growth company," as defined in the Jumpstart Our Business Startups Act ("JOBS Act"). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies.

We expect to elect to use this extended transition period to enable us to comply with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that we (i) are no longer an emerging growth company or (ii) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

**Item 3. Quantitative and Qualitative Disclosures About Market Risk**

As a "smaller reporting company" as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended, (the "Exchange Act") and pursuant to Item 305 of Regulation S-K, we are not required to disclose information under this section.

[**Table of Contents**](#HK_001)

**Item 4. Controls and Procedures**

***Evaluation of Disclosure Controls and Procedures***

 ****

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2026, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act.

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure. Based upon the evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls were not effective as of March 31, 2026, based on the material weaknesses identified below.

***Material Weakness in Internal Control over Financial Reporting***

 ****

As discussed in the 2025 Report, the Company disclosed a material weakness in internal controls over financial reporting. Management has concluded this material weakness has not been remediated as an internal control deficiency was identified relating to the lack in investment of resources into accounting and reporting functions to properly account for and prepare U.S. GAAP compliant financial statements on a timely basis and to properly document risks affecting financial statements and controls in place to mitigate those risks in accordance with the requirements for a functioning internal control system. Notwithstanding this material weakness, management has concluded that our unaudited condensed consolidated financial statements included in the 2025 Report are fairly stated in all material respects in accordance with U.S. GAAP for each of the periods presented herein.

This material weakness could result in a misstatement of account balances or disclosures that would result in a material misstatement of our annual or interim consolidated financial statements that may not be detected.

***Plan for Remediation of the Material Weakness in Internal Control over Financial Reporting***

 ****

In response, the Company's management has continued implementation of a plan to remediate this material weakness. These remediation measures are ongoing and include the following; hiring a Chief Financial Officer, which was completed in the fourth quarter of 2024, and adding additional review procedures by qualified personnel over complex accounting matters, which include engaging third-party professionals with whom to consult regarding complex accounting applications.

The material weaknesses will be considered remediated once management completes the design and implementation of the measures described above and the controls operate for a sufficient period of time, and management has concluded, through testing, that these controls are effective. We believe we are making progress toward achieving the effectiveness of our internal controls and disclosure controls; however, we cannot provide any assurance that these remediation efforts will be successful or that our internal control over financial reporting will be effective as a result of these efforts.

***Changes in Internal Control over Financial Reporting***

 ****

Other than the changes made to the material weakness described above, there were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rules 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the three months ended March 31, 2026, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

***Limitations on the Effectiveness of Disclosure Controls and Procedures***

 ****

Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures or internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well designed and implemented, can provide only reasonable, not absolute, assurance that the control system's objectives will be met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues within a company are detected. The inherent limitations include the realities that judgments in decision-making can be faulty and that

breakdowns can occur because of simple errors or mistakes. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and may not be detected. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.

[**Table of Contents**](#HK_001)

***Part II. Other Information***

**Item 1. Legal Proceedings**

On January 16, 2025, the Company filed a lawsuit against AFG and its Chief Executive Officer, Ralph Wright Brewer III, in the Northern District of Texas, Dallas Division alleging fraudulent misrepresentation, breach of contract, and the concealment of a ransomware attack on its own network shortly before the Reseller Agreement was executed. Given that the litigation remains in its early stages, the Company is currently unable to estimate the potential range of recoverable damages or the potential loss or range of loss, if any, resulting from a favorable or unfavorable outcome.

On March 26, 2025, the Company filed a First Amended Complaint against AFG in the Southern District of New York alleging breach of contract against AFG with respect to the AFG Subscription Agreement. Specifically, the Company alleges that AFG failed to fund its required March 13, 2025 payment in the amount of $6,500,000. In the lawsuit, the Company seeks actual damages in the amount of the missed payment, pre- and post-judgment interest, consequential damages and attorneys' fees and costs. It also seeks a declaration from the court that AFG was and is obligated to purchase an aggregate of $6.5 million of additional shares of the Company's Common Stock on each of the first four anniversaries of the Initial Offering Closing Date and Business Combination Closing (as defined in the AFG Subscription Agreement) pursuant to the AFG Subscription Agreement. On May 12, 2025, AFG filed an Answer and Counterclaims in which it denies the allegations of the lawsuit and asserts counterclaims for an unspecified amount of damages against the Company. Given that the litigation remains in its early stages, the Company is currently unable to estimate the potential range of recoverable damages or the potential loss or range of loss, if any, resulting from a favorable or unfavorable outcome.

From time to time, we may become involved in legal proceedings or be subject to claims arising in the ordinary course of our business. Apart from the foregoing, we are not presently a party to any other legal proceedings that we believe, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, cash flows or financial condition. Defending such proceedings is costly and can impose a significant burden on management and employees. The results of any current or future litigation cannot be predicted with certainty, and regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.

**Item 1A. Risk Factors**

As of the date of this Report, there have been no material changes from the risk factors disclosed in our 2025 Annual Report. Any of these factors could result in a significant or material adverse effect on our result of operations or financial conditions. Additional risk factors not presently known to us may also impair our business or results of operations. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds**

None.

**Item 3. Defaults Upon Senior Securities**

None.

**Item 4. Mine Safety Disclosures**

Not applicable.

**Item 5. Other Information**

*2026 Annual Meeting of Shareholders*

The Company's Board of Directors has not yet established the date of the Company's 2026 annual meeting of shareholders. When the date is established, the Company will announce it in its filings made with the SEC.

*Director and Officer Trading Arrangements*

None of our directors or officers adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (as such terms are defined in Items 408(a) and 408(c) of Regulation S-K, respectively) during the quarterly period covered by this Report.

[**Table of Contents**](#HK_001)

**Item 6. Exhibits**

The exhibits listed below are filed as part of this Report or incorporated herein by reference:

---

| | |
|:---|:---|
| **Exhibit** | **Description** |
| 2.1#^ | [Business Combination Agreement and Plan of Reorganization, dated as of September 7, 2023, by and among Brand Engagement Network Inc., BEN Merger Subsidiary Corp., DHC Acquisition Corp and, solely with respect to Section 7.21 and 9.03 thereto, DHC Sponsor, LLC (incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on September 8, 2023).](https://www.sec.gov/Archives/edgar/data/1838163/000119312523230794/d507211dex21.htm) |
| 2.2# | [Share Purchase and Transfer Agreement, dated October 29, 2024, by and among Brand Engagement Network Inc., Christian Unterseer, CUTV GmbH and CUNEO AG (incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K (File No. 001-40130) filed with the Securities and Exchange Commission on October 30, 2024).](https://www.sec.gov/Archives/edgar/data/1838163/000149315224043006/ex2-1.htm) |
| 2.3 | [Addendum to Share Purchase and Transfer Agreement, dated February 6, 2025, by and among Brand Engagement Network Inc., Christian Unterseer, CUTV GmbH and CUNEO AG (incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K (File No. 001-40130) filed with the Securities and Exchange Commission on February 12, 2025).](https://www.sec.gov/Archives/edgar/data/1838163/000149315225006153/ex2-1.htm) |
| 2.4 | [Addendum II to Share Purchase and Transfer Agreement, dated May 26, 2025, by and among Brand Engagement Network Inc., Christian Unterseer, CUTV GmbH and CUNEO AG (incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K (File No. 001-40130) filed with the Securities and Exchange Commission on May 30, 2025).](https://www.sec.gov/Archives/edgar/data/1838163/000164117225012964/ex2-1.htm) |
| 3.1 | [Certificate of Incorporation of Brand Engagement Network Inc. (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K (File No. 001-40130) filed with the Securities and Exchange Commission on March 20, 2024).](https://www.sec.gov/Archives/edgar/data/1838163/000149315224010698/ex3-1.htm) |
| 3.2 | [Certificate of Amendment (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K (File No. 001-40130) filed with the Securities Exchange Commission on December 1, 2025).](https://www.sec.gov/Archives/edgar/data/1838163/000149315225025613/ex3-1.htm) |
| 3.3 | [Bylaws of Brand Engagement Network Inc. (incorporated by reference to Exhibit 3.2 to the Company's Current Report on Form 8-K (File No. 001-40130) filed with the Securities and Exchange Commission on March 20, 2024).](https://www.sec.gov/Archives/edgar/data/1838163/000149315224010698/ex3-2.htm) |
| 3.4 | [Amendment No.1 to Bylaws of Brand Engagement Networks, Inc. (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K (File No. 001-40130) filed with the Securities Exchange Commission on November 28, 2025).](https://www.sec.gov/Archives/edgar/data/1838163/000149315225025376/ex3-1.htm) |
| 31.1\* | [Certification of Principal Executive Officer in accordance with 18 U.S.C. Section 1350, as adopted by Section 302 of the Sarbanes-Oxley Act of 2002.](ex31-1.htm) |
| 31.2\* | [Certification of Principal Financial Officer in accordance with 18 U.S.C. Section 1350, as adopted by Section 302 of the Sarbanes-Oxley Act of 2002.](ex31-2.htm) |
| 32.1\*\* | [Certification of Principal Executive Officer in accordance with 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002.](ex32-1.htm) |
| 32.2\*\* | [Certification of Principal Financial Officer in accordance with 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002.](ex32-2.htm) |
| 101\* | The following financial information from Brand Engagement Network Inc.'s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 formatted in Inline XBRL (Extensible Business Reporting Language) includes: (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Operations, (iii) the Condensed Consolidated Statements of Changes in Stockholders' Equity, (iv) the Condensed Consolidated Statements of Cash Flows, and (v) Notes to the Condensed Consolidated Financial Statements. |
| 101.INS\* | Inline XBRL Instance Document. |
| 101.SCH\* | Inline XBRL Taxonomy Extension Schema Document. |
| 101.CAL\* | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
| 101.DEF\* | Inline XBRL Taxonomy Extension Definition Linkbase Document. |
| 101.LAB\* | Inline XBRL Taxonomy Extension Labels Linkbase Document. |
| 101.PRE\* | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
| 104\* | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |

---

\* Filed herewith

\*\* The certifications as Exhibit 32.1 and Exhibit 32.2 are not deemed "filed" with the Securities and Exchange Commission and are not to be incorporated by the reference into any filing of Brand Engagement Network Inc. under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Report, irrespective of any general incorporation language contained in such filing.

# Schedules to this exhibit have been omitted pursuant to Item 601(b)(2) of Registration S-K. The registrant hereby agrees to furnish a copy of any omitted schedules to the Commission upon request.

^ Certain information has been redacted from this exhibit pursuant to Item 601(b)(10)(iv) of Regulation S-K because it is both not material and is the type of information that the registrant customarily and actually treats as private or confidential. The registrant hereby undertakes to furnish supplemental copies of the unredacted exhibit upon request by the SEC.

[**Table of Contents**](#HK_001)

**SIGNATURES**

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Brand Engagement Network Inc. (Registrant)

---

| | | |
|:---|:---|:---|
| Date: May 15, 2026 | By: | */s/ Tyler Luck* |
|  | Name: | Tyler Luck |
|  | Title: | Chief Executive Officer |
|  |  | (Duly Authorized Officer and Principal Executive Officer) |
| Date: May 15, 2026 | By: | */s/ Walid Khiari* |
|  | Name: | Walid Khiari |
|  | Title: | Chief Financial Officer and Chief Operating Officer |
|  |  | (Principal Financial Officer) |

---

## Exhibit 31.1

**Exhibit 31.1**

 **BRAND ENGAGEMENT NETWORK INC.**

**CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Tyler Luck, certify that:

1. I have reviewed this Quarterly
 Report on Form 10-Q of Brand Engagement Network Inc. for the period ended March 31, 2026;

2. Based on my knowledge,
 this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
 made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this
 report;

3. Based on my knowledge,
 the financial statements, and other financial information included in this report, fairly present in all material respects the financial
 condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's
 other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in
 Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act
 Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;(a) designed such disclosure
 controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material
 information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities,
 particularly during the period in which this report is being prepared;

(b) designed such internal
 control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision,
 to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
 external purposes in accordance with generally accepted accounting principles;

(c) evaluated the effectiveness
 of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness
 of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) disclosed in this report
 any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent
 fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control
 over financial reporting; and

5. The registrant's
 other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting,
 to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the
 equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;(a) all significant deficiencies
 and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely
 affect the registrant's ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not
 material, that involves management or other employees who have a significant role in the registrant's internal control over
 financial reporting.

---

| | |
|:---|:---|
| By: | */s/ Tyler Luck* |
|  | Tyler Luck |
|  | Acting Chief Executive Officer |
|  | (Principal Executive Officer) |
| Date: | May 15, 2026 |

---

## Exhibit 31.2

**Exhibit 31.2**

 **BRAND ENGAGEMENT NETWORK INC.**

**CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Walid Khiari, certify that:

1. I have reviewed this Quarterly
 Report on Form 10-Q of Brand Engagement Network Inc. for the period ended March 31, 2026;

2. Based on my knowledge,
 this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
 made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this
 report;

3. Based on my knowledge,
 the financial statements, and other financial information included in this report, fairly present in all material respects the financial
 condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's
 other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in
 Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act
 Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;(a) designed such disclosure
 controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material
 information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities,
 particularly during the period in which this report is being prepared;

(b) designed such internal
 control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision,
 to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
 external purposes in accordance with generally accepted accounting principles;

(c) evaluated the effectiveness
 of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness
 of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) disclosed in this report
 any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent
 fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control
 over financial reporting; and

5. The registrant's
 other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting,
 to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the
 equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;(a) all significant deficiencies
 and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely
 affect the registrant's ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not
 material, that involves management or other employees who have a significant role in the registrant's internal control over
 financial reporting.

---

| | |
|:---|:---|
| By: | */s/ Walid Khiari* |
|  | Walid Khiari |
|  | Chief Financial Officer |
|  | (Principal Financial and Accounting Officer) |
| Date: | May 15, 2026 |

---

## Exhibit 32.1

**Exhibit 32.1**

**BRAND ENGAGEMENT NETWORK INC.**

**CERTIFICATION PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with this Quarterly Report on Form 10-Q of Brand Engagement Network Inc. (the "Company") for the period ended March 31, 2026 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

---

| | |
|:---|:---|
| By: | */s/ Tyler Luck* |
|  | Tyler Luck |
|  | Acting Chief Executive Officer |
|  | (Principal Executive Officer) |
| Date: | May 15, 2026 |

---

## Exhibit 32.2

**Exhibit 32.2**

**BRAND ENGAGEMENT NETWORK INC.**

**CERTIFICATION PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with this Quarterly Report on Form 10-Q of Brand Engagement Network Inc. (the "Company") for the period ended March 31, 2026 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

---

| | |
|:---|:---|
| By: | */s/ Walid Khiari* |
|  | Walid Khiari |
|  | Chief Financial Officer |
|  | (Principal Financial and Accounting Officer) |
| Date: | May 15, 2026 |

---